Form 4: Tenaya Therapeutics CEO Faraz Ali Sells Shares to Cover Tax Obligations

CEO Faraz Ali sold shares of Tenaya Therapeutics to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Faraz Ali, CEO of Tenaya Therapeutics, sold shares of the company's common stock on August 16, 2024.
• The sales were executed in two separate transactions to cover tax withholding obligations related to the vesting of restricted stock units.
• In the first transaction, 5,802 shares were sold at a weighted average price of $2.8945.
• In the second transaction, 3,946 shares were sold at the same weighted average price of $2.8945.
• Following these transactions, Ali directly owns 188,331 shares, which includes 152,500 shares issuable upon vesting of restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the stock sales appear to be routine transactions to cover tax obligations, with no indication of insider concerns about the company's prospects.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. It's important to consider the context of these sales, such as the executive's overall holdings and the company's performance, to determine if they signal any concerns.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders if they perceive the sales negatively, but the impact is likely minimal given the stated reason for the sales.

Key Dates